Literature DB >> 20173773

Cancer: Risk of hypogonadism in male survivors of childhood cancer.

Tomas Ahern, Frances J Hayes.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20173773     DOI： 10.1038/nrendo.2009.277

Source DB:  PubMed          Journal:  Nat Rev Endocrinol        ISSN： 1759-5029            Impact factor:   43.330


× No keyword cloud information.
  8 in total

1.  Testosterone therapy in adult men with androgen deficiency syndromes: an endocrine society clinical practice guideline.

Authors:  Shalender Bhasin; Glenn R Cunningham; Frances J Hayes; Alvin M Matsumoto; Peter J Snyder; Ronald S Swerdloff; Victor M Montori
Journal:  J Clin Endocrinol Metab       Date:  2006-05-23       Impact factor: 5.958

2.  Neuroendocrine-gonadal axis in men: frequent sampling of LH, FSH, and testosterone.

Authors:  D I Spratt; L S O'Dea; D Schoenfeld; J Butler; P N Rao; W F Crowley
Journal:  Am J Physiol       Date:  1988-05

3.  Loss of circadian rhythmicity in blood testosterone levels with aging in normal men.

Authors:  W J Bremner; M V Vitiello; P N Prinz
Journal:  J Clin Endocrinol Metab       Date:  1983-06       Impact factor: 5.958

4.  Long-term pharmacokinetics of transdermal testosterone gel in hypogonadal men.

Authors:  R S Swerdloff; C Wang; G Cunningham; A Dobs; A Iranmanesh; A M Matsumoto; P J Snyder; T Weber; J Longstreth; N Berman
Journal:  J Clin Endocrinol Metab       Date:  2000-12       Impact factor: 5.958

5.  Randomized placebo-controlled trial of testosterone replacement in men with mild Leydig cell insufficiency following cytotoxic chemotherapy.

Authors:  S J Howell; J A Radford; J E Adams; E M Smets; R Warburton; S M Shalet
Journal:  Clin Endocrinol (Oxf)       Date:  2001-09       Impact factor: 3.478

6.  Prevalence and consequences of androgen deficiency in young male cancer survivors in a controlled cross-sectional study.

Authors:  D M Greenfield; S J Walters; R E Coleman; B W Hancock; R Eastell; H A Davies; J A Snowden; L Derogatis; S M Shalet; R J M Ross
Journal:  J Clin Endocrinol Metab       Date:  2007-06-19       Impact factor: 5.958

7.  Hypogonadism risk in men treated for childhood cancer.

Authors:  Patrik Romerius; Olof Ståhl; Christian Moëll; Thomas Relander; Eva Cavallin-Ståhl; Thomas Wiebe; Yvonne Lundberg Giwercman; Aleksander Giwercman
Journal:  J Clin Endocrinol Metab       Date:  2009-09-29       Impact factor: 5.958

8.  Prevalence of symptomatic androgen deficiency in men.

Authors:  Andre B Araujo; Gretchen R Esche; Varant Kupelian; Amy B O'Donnell; Thomas G Travison; Rachel E Williams; Richard V Clark; John B McKinlay
Journal:  J Clin Endocrinol Metab       Date:  2007-08-14       Impact factor: 5.958
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.